Clinical Trials Logo

Pleural Effusion clinical trials

View clinical trials related to Pleural Effusion.

Filter by:

NCT ID: NCT04749602 Completed - Clinical trials for Non-small Cell Lung Cancer Metastatic

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Start date: August 10, 2020
Phase: Phase 2
Study type: Interventional

Patients with advanced cancers who have pleural effusion, especially those requiring pleural evacuation, experienced poorer survival when treated with immunotherapy. The pleura also acts as a natural barrier that can limit the penetration of immune checkpoint inhibitors. In this multicenter phase 2 study, the preliminary efficacy and toxicity of intrapleural instillation of the nivolumab in patients with immune-sensitive metastatic cancers will be accessed.

NCT ID: NCT04684459 Recruiting - Clinical trials for Pleural Effusion, Malignant

Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis

Start date: March 12, 2021
Phase: Early Phase 1
Study type: Interventional

Serosal cavity metastasis of malignant tumor is one of the late complications, which seriously affects the quality of life and survival time of patients. HER-2 is frequently expressed in breast cancer, ovarian cancer, lung cancer, gastric cancer and other malignant tumors. The HER-2/PD-L1 dual-targeting CAR-T will be investigated in patients with HER2 positive solid tumor serosal cavity metastases.

NCT ID: NCT04683419 Recruiting - Pleural Effusion Clinical Trials

Modified Thoracoscopic Pleural Cryobiopsy in Diagnosis of Exudative Pleural Effusion

Start date: November 11, 2020
Phase: N/A
Study type: Interventional

Background: Rigid thoracoscopy is the gold standard tool for diagnosing exudative pleural effusion but sometimes it is difficult to obtain sufficient biopsies using the conventional forceps. Objectives: This study evaluated the efficacy, safety and diagnostic value of a modified technique using cryoprobe to obtain pleural biopsies during thoracoscopy. Methods: This is a single center prospective study in patients who will undergo rigid thoracoscopy using conventional rigid forceps followed by a cryoprobe from the same site after injection of subpleural mixture of adrenaline and xylocaine. Biopsies will be reviewed by an independent pathologist; any complications will be recorded, and all patients will be followed up post procedure.

NCT ID: NCT04670562 Recruiting - Prognosis Clinical Trials

Longitudinal Follow up of Patients With Pleural Effusion

Start date: March 1, 2021
Phase:
Study type: Observational [Patient Registry]

This study aims to evaluate the clinical course of patients diagnosed with pleural effusion and determine various clinical factors and biomarkers associated that can predict the diagnosis and clinical outcome and prognosis of patients with pleural effusion due to specific causes.

NCT ID: NCT04669223 Recruiting - Clinical trials for Pleural Effusion, Malignant

Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Malignant pleural effusion (MPE) is a very common medical condition, especially among patients with disseminated cancers. Chest drain insertion aims to drain the pleural fluid collection and relieve dyspnea. Small bore chest tubes are recommended as the first line therapy for draining pleural effusions. However, there is no clinical data available to inform on the size of drains for better drainage. This is a randomized study comparing the two common bores of small bore chest drains in Hong Kong, and assess for its clinical efficacy and complication risks.

NCT ID: NCT04553315 Completed - Complication Clinical Trials

the Effect of Chest Expansion Exercises on Pleural Effusion

PE
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

the study attempted to assess and evaluate the efficacy of implementing chest expansion exercises on patients with pleural effusion and how this programme contribute to reduce pulmonary infection and complications. To address the objective of the study, the researcher utilized chest expansion exercises consisted of stacked breathing exercise, segmental breathing, chest mobility exercises, deep breathing exercise with use of incentve spirometer and assess the patient before and after exercises by using three tools help to monitor hemodynamic parameters, chest condition, laboratory investigations which help to evaluate pulmonary infection score and complications.

NCT ID: NCT04533854 Completed - Pleural Effusion Clinical Trials

Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Analysis

SPECTRA
Start date: March 26, 2021
Phase:
Study type: Observational

Lung cancer is a common cancer, associated with a high mortality rate. Pleural effusions are common in lung cancer, developing in up to 40% of patients. Ascites is common in patients with abdominal malignancies and can be the presenting feature in up to 50% of patients. There is a need for new techniques to improve our diagnostic ability of cancer. FTIR technology could enable a point-of-care test that would provide an initial diagnosis that may determine a change in treatment at the time of the investigation.

NCT ID: NCT04438317 Completed - Pleural Effusion Clinical Trials

Thoracic Drains in Intensive Care Units: Comparison of Seldinger and Surgical Methods

DrainICU
Start date: May 29, 2020
Phase: N/A
Study type: Interventional

This prospective randomized multicenter study is intended to investigate tolerance and effectiveness of thoracic drainage conducted by Seldinger technique with small drains, or by a surgical-like technique with large armed drains, in intensive care units patients.

NCT ID: NCT04420663 Completed - Clinical trials for Thoracocentesis of Pleural Effusion

Pleural Manometry in Thoracocentesis

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The study aiming to measure the pleural pressure during thoracocentesis in patients with pleural effusion and the value of their measurement in both diagnostic and therapeutic decisions.

NCT ID: NCT04418804 Recruiting - Pleural Effusion Clinical Trials

Diagnosis and Classification of Pleural Diseases Using Ultrasound Channel Data

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Background: The Pleura is a double-layered membrane that surrounds the lungs. Pathological processes that involve the Pleura are called "Pleural diseases". Among them are included Pneumothorax (Air the chest cavity), Pleural effusions, and tumor formation. Ultrasound imaging of the Pleura to detect and assess pleural diseases has been proven as an excellent diagnostic and safe option. Ultrasound test uses sound waves to characterize the structure and function of different organs in health and disease. The standard technique used to create two-dimensional ultrasound picture is called Delay and Sum (DAS). Signals are transmitted and received from a series of elements and allow a two dimensional picture to be created. Because a large number of sensors is required, creating a two dimensional picture creates a large and usually redundant data pool. This fact leads to a need for stronger processors and larger operating systems, Consumption of higher energy, and hence an ungainly, slow, and expensive system. Signal Acquisition Modeling and Processing Laboratory (SAMPLE) in Weizmann institute has developed a data processing system that allows narrowing down the number of elements needed to process the ultrasound signal, while creating an ultrasound picture of abdominal organs in a satisfying resolution. Sometimes even better than standard methods. Research goal: Improvement of diagnosis and characterization of pleural diseases by Ultrasound, using a novel algorithm that was developed in SAMPLE laboratory in Weizmann Institute. The aim is to create a faster, more reliable ultrasound imaging while minimizing sampling rate and data volume. Methods: Tested population: Women and/or men who were diagnosed with Pneumothorax or Plural effusion with other imaging modalities, and healthy volunteers as a control group, Up to 30 participants per each group (Total up to 90), in a 1:1:1 Ratio. Research type: An open-labeled study. Experimental design: Participants that will meet the required conditions will be summoned to an exam in our imaging institute or will be scanned bedside, using the Verasonics ultrasound system, which allows free access to ultrasound raw Channel data. The information acquired, as well as other imaging scans of the participant, will be coded and delivered anonymously to SAMPLE laboratory for analysis.